China Dengue Testing Market Report & Forecast 2021-2027

This report contains market size and forecasts of Dengue Testing in China, including the following market information:
China Dengue Testing Market Revenue, 2016-2021, 2022-2027, ($ millions)
China top five Dengue Testing companies in 2020 (%)
The global Dengue Testing market size is expected to growth from US$ 229.2 million in 2020 to US$ 299.9 million by 2027; it is expected to grow at a CAGR of 3.5% during 2021-2027.
The China Dengue Testing market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Dengue Testing Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Dengue Testing Market,

By Type

, 2016-2021, 2022-2027 ($ Millions)
China Dengue Testing Market Segment Percentages,

By Type

, 2020 (%)
ELISA-Based Tests
RT-PCR Based Tests
Dengue IgG/IgM Rapid Test

China Dengue Testing Market,

By Application

, 2016-2021, 2022-2027 ($ Millions)
China Dengue Testing Market Segment Percentages,

By Application

, 2020 (%)
Hospitals
Public Health Laboratory
Diagnostic Centers
Others

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dengue Testing revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Dengue Testing revenues share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abnova
Roche Molecular Systems
Abbott Laboratories
InBios International
NovaTec Immundiagnostica
Sub.PerkinElmer
Quest Diagnostics
Certest Biotec
OriGene Technologies
Thermo Fisher